Environmental Exposures and Polycystic Ovary Syndrome: A Review

Abstract

Polycystic ovary syndrome (PCOS) is the most common heterogeneous endocrine disorder in women of reproductive age, affecting around 5 to 10% of women and up to 21% depending on the applied diagnostic criteria and study population. People with PCOS may experience oligomenorrhea, androgen excess, and polycystic ovary morphology. The etiology of the disease is not completely understood, with genetics, epigenetics, endocrine, metabolic, lifestyle, and environmental factors contributing to its development and severity. Environmental exposures are an important, burgeoning field in menstrual research, as they potentially link to menstrual cycle disruption and the risk of reproductive disorders such as PCOS. This review examines the recent research investigating environmental exposures—air pollution, micro- and nanoplastics, heavy metals, and endocrine-disrupting chemicals—and PCOS in human and animal models, concluding with potential mechanisms, limitations, and considerations for future work. Overall, research on environmental exposures and PCOS is limited and yields heterogeneous results across studies. Specifically, exposures such as air pollutants, micro- and nanoplastics, persistent organic pollutants, and parabens have noticeably limited research. Future research can help fill the gap in understanding how environmental exposures, particularly across gestational, childhood, and reproductive adult life stages, may impact PCOS.

Keywords

environmental exposures - polycystic ovary syndrome - endocrine-disrupting chemicals - microplastics - per- and polyfluoroalkyl substances

Publikationsverlauf

Artikel online veröffentlicht:
05. Februar 2025

• References

• 1 Popat VB, Prodanov T, Calis KA, Nelson LM. The menstrual cycle: a biological marker of general health in adolescents. Ann N Y Acad Sci 2008; 1135: 43-51
• 2 Munro MG, Critchley HOD, Fraser IS. FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet 2018; 143 (03) 393-408
• 3 Pivonello R, Diamanti-Kandarakis E. eds. Environmental Endocrinology and Endocrine Disruptors: Endocrine and Endocrine-Targeted Actions and Related Human Diseases. Springer International Publishing; 2023.
• 4 Diaz A, Laufer MR, Breech LL. American Academy of Pediatrics Committee on Adolescence, American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics 2006; 118 (05) 2245-2250
• 5 Attia GM, Alharbi OA, Aljohani RM. The impact of irregular menstruation on health: a review of the literature. Cureus 2023; 15 (11) e49146
• 6 Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis 2017; 11 (08) 215-225
• 7 Wang YX, Arvizu M, Rich-Edwards JW. et al. Menstrual cycle regularity and length across the reproductive lifespan and risk of premature mortality: prospective cohort study. BMJ 2020; 371: m3464
• 8 Rutkowska AZ, Diamanti-Kandarakis E. Polycystic ovary syndrome and environmental toxins. Fertil Steril 2016; 106 (04) 948-958
• 9 Roumain J, Charles MA, de Courten MP. et al. The relationship of menstrual irregularity to type 2 diabetes in Pima Indian women. Diabetes Care 1998; 21 (03) 346-349
• 10 Solomon CG, Hu FB, Dunaif A. et al. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 2001; 286 (19) 2421-2426
• 11 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81 (01) 19-25
• 12 Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90 (04) 1929-1935
• 13 Hart R. PCOS and infertility. Panminerva Med 2008; 50 (04) 305-314
• 14 Solomon CG, Hu FB, Dunaif A. et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab 2002; 87 (05) 2013-2017
• 15 Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R. Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences. J Clin Endocrinol Metab 2022; 107 (02) 575-585
• 16 Azziz R. PCOS in 2015: new insights into the genetics of polycystic ovary syndrome. Nat Rev Endocrinol 2016; 12 (02) 74-75
• 17 Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 2018; 14 (05) 270-284
• 18 Srnovršnik T, Virant-Klun I, Pinter B. Polycystic ovary syndrome and endocrine disruptors (bisphenols, parabens, and triclosan) - a systematic review. Life (Basel) 2023; 13 (01) 138
• 19 Zhu T, Goodarzi MO. Causes and consequences of polycystic ovary syndrome: insights from Mendelian randomization. J Clin Endocrinol Metab 2022; 107 (03) e899-e911
• 20 Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci 2019; 236: 116940
• 21 Kshetrimayum C, Sharma A, Mishra VV, Kumar S. Polycystic ovarian syndrome: Environmental/occupational, lifestyle factors; an overview. J Turk Ger Gynecol Assoc 2019; 20 (04) 255-263
• 22 Lum JTS, Chan YN, Leung KSY. Current applications and future perspectives on elemental analysis of non-invasive samples for human biomonitoring. Talanta 2021; 234: 122683
• 23 Azzouz A, Rascón AJ, Ballesteros E. Simultaneous determination of parabens, alkylphenols, phenylphenols, bisphenol A and triclosan in human urine, blood and breast milk by continuous solid-phase extraction and gas chromatography-mass spectrometry. J Pharm Biomed Anal 2016; 119: 16-26
• 24 Klotz K, Weistenhöfer W, Drexler H. Determination of Cadmium in Biological Samples. In: Sigel A, Sigel H, Sigel RK. eds. Cadmium: From Toxicity to Essentiality. The Netherlands:: Springer; 2013: 85-98
• 25 Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJR, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 2010; 118 (08) 1055-1070
• 26 Calafat AM, Weuve J, Ye X. et al. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect 2009; 117 (04) 639-644
• 27 Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 2002; 17 (11) 2839-2841
• 28 Schönfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 2002; 110 (11) A703-A707
• 29 LaKind JS, Amina Wilkins A, Berlin Jr CM. Environmental chemicals in human milk: a review of levels, infant exposures and health, and guidance for future research. Toxicol Appl Pharmacol 2004; 198 (02) 184-208
• 30 Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007; 24 (02) 139-177
• 31 Silva EL, Walker DI, Coates Fuentes Z. et al. Untargeted metabolomics reveals that multiple reproductive toxicants are present at the endometrium. Sci Total Environ 2022; 843: 157005
• 32 Gutvirtz G, Sheiner E. Airway pollution and smoking in reproductive health. Best Pract Res Clin Obstet Gynaecol 2022; 85 (Pt B): 81-93
• 33 World Health Organization. Ambient (Outdoor) Air Pollution. World Health Organization. December 19, 2022 . Accessed June 26, 2024 at: https://www.who.int/news-room/fact-sheets/detail/ambient-(outdoor)-air-quality-and-health
• 34 Klepeis NE, Nelson WC, Ott WR. et al. The National Human Activity Pattern Survey (NHAPS): a resource for assessing exposure to environmental pollutants. J Expo Anal Environ Epidemiol 2001; 11 (03) 231-252
• 35 Spengler JD. Indoor air pollution. N Engl Reg Allergy Proc 1985; 6 (02) 126-134
• 36 Lin SY, Yang YC, Chang CYY. et al. Risk of polycystic ovary syndrome in women exposed to fine air pollutants and acidic gases: a nationwide cohort analysis. Int J Environ Res Public Health 2019; 16 (23) 4816
• 37 Kim JH, Hong SH, Moon NL, Kang DR. Effects of exposure duration and exposure levels of ambient air pollutants on the risk of polycystic ovarian syndrome: a 2015-2019 Korean Population-Based Cohort Study. Toxics 2022; 10 (09) 542
• 38 Ye X, Pan W, Li C. et al. Exposure to polycyclic aromatic hydrocarbons and risk for premature ovarian failure and reproductive hormones imbalance. J Environ Sci (China) 2020; 91: 1-9
• 39 Huddleston HG, Jaswa EG, Casaletto KB. et al. Associations of polycystic ovary syndrome with indicators of brain health at midlife in the CARDIA cohort. Neurology 2024; 102 (04) e208104
• 40 Tay CT, Loxton D, Bahri Khomami M, Teede H, Harrison CL, Joham AE. High prevalence of medical conditions and unhealthy lifestyle behaviours in women with PCOS during preconception: findings from the Australian Longitudinal Study on Women's Health. Hum Reprod 2023; 38 (11) 2267-2276
• 41 Zhang B, Zhou W, Shi Y, Zhang J, Cui L, Chen ZJ. Lifestyle and environmental contributions to ovulatory dysfunction in women of polycystic ovary syndrome. BMC Endocr Disord 2020; 20 (01) 19
• 42 Valgeirsdottir H, Vanky E, Sundström-Poromaa I. et al. Prenatal exposures and birth indices, and subsequent risk of polycystic ovary syndrome: a national registry-based cohort study. BJOG 2019; 126 (02) 244-251
• 43 Boldis BV, Grünberger I, Cederström A, Björk J, Nilsson A, Helgertz J. Early life factors and polycystic ovary syndrome in a Swedish Birth Cohort. Int J Environ Res Public Health 2023; 20 (22) 7083
• 44 United Nations Economic Commission for Europe. Mean age of women at birth of first child - Data Portal. Accessed November 5, 2024 at: https://w3.unece.org/PXWeb/en/Table?IndicatorCode=34
• 45 Yang Q, Zhao Y, Qiu X, Zhang C, Li R, Qiao J. Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study. Hum Reprod 2015; 30 (08) 1964-1973
• 46 Rafiee A, Hoseini M, Akbari S, Mahabee-Gittens EM. Exposure to polycyclic aromatic hydrocarbons and adverse reproductive outcomes in women: current status and future perspectives. Rev Environ Health 2023; 39 (02) 305-311
• 47 Ghetu CC, Rohlman D, Smith BW. et al. Wildfire impact on indoor and outdoor PAH air quality. Environ Sci Technol 2022; 56 (14) 10042-10052
• 48 Seow WJ, Hu W, Vermeulen R. et al. Household air pollution and lung cancer in China: a review of studies in Xuanwei. Chin J Cancer 2014; 33 (10) 471-475
• 49 Zheng Y, Gan X, Lin C. et al. Polystyrene nanoplastics cause reproductive toxicity in zebrafish: PPAR mediated lipid metabolism disorder. Sci Total Environ 2024; 931: 172795
• 50 Hale RC, Seeley ME, La Guardia MJ, Mai L, Zeng EY. A global perspective on microplastics. J Geophys Res 2020; 125 (01)
• 51 Adhikari M, Biswas C, Mazumdar P, Sarkar S, Pramanick K. Evaluating the potential of daily intake of polystyrene microplastics via drinking water in inducing PCOS and its ovarian fibrosis progression using female zebrafish. NanoImpact 2024; 34: 100507
• 52 Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ. Heavy metal toxicity and the environment. Experientia Suppl 2012; 101: 133-164
• 53 Rumph JT, Stephens VR, Martin JL. et al. Uncovering evidence: associations between environmental contaminants and disparities in women's health. Int J Environ Res Public Health 2022; 19 (03) 1257
• 54 Merlo E, Schereider IRG, Simões MR, Vassallo DV, Graceli JB. Mercury leads to features of polycystic ovary syndrome in rats. Toxicol Lett 2019; 312: 45-54
• 55 da Costa CS, Oliveira TF, Freitas-Lima LC. et al. Subacute cadmium exposure disrupts the hypothalamic-pituitary-gonadal axis, leading to polycystic ovarian syndrome and premature ovarian failure features in female rats. Environ Pollut 2021; 269: 116154
• 56 Kanafchian M, Esmaeilzadeh S, Mahjoub S, Rahsepar M, Ghasemi M. Status of serum copper, magnesium, and total antioxidant capacity in patients with polycystic ovary syndrome. Biol Trace Elem Res 2020; 193 (01) 111-117
• 57 Kirmizi DA, Baser E, Turksoy VA, Kara M, Yalvac ES, Gocmen AY. Are heavy metal exposure and trace element levels related to metabolic and endocrine problems in polycystic ovary syndrome?. Biol Trace Elem Res 2020; 198 (01) 77-86
• 58 Pokorska-Niewiada K, Brodowska A, Szczuko M. The content of minerals in the PCOS group and the correlation with the parameters of metabolism. Nutrients 2021; 13 (07) 2214
• 59 Zhang C, Xu L, Zhao Y, Wang Y. Changes in serum heavy metals in polycystic ovary syndrome and their association with endocrine, lipid-metabolism, inflammatory characteristics and pregnancy outcomes. Reprod Toxicol 2022; 111: 20-26
• 60 Liang D, Moutinho JL, Golan R. et al. Use of high-resolution metabolomics for the identification of metabolic signals associated with traffic-related air pollution. Environ Int 2018; 120: 145-154
• 61 Abudawood M, Alnuaim L, Tabassum H. et al. An insight into the impact of serum tellurium, thallium, osmium and antimony on the antioxidant/redox status of PCOS patients: a comprehensive study. Int J Mol Sci 2023; 24 (03) 2596
• 62 Abbasi S, Mohebbi M, Mousavi Vahed SH. et al. Comparison of magnesium status using 24-h urine magnesium content and magnesium fraction excretion in PCOS with non-PCOS control women: a cross-sectional study. Biol Trace Elem Res 2023; 201 (12) 5601-5606
• 63 Sharma P, Kapoor HS, Kaur B, Kamra P, Khetarpal P. Investigation of the association of serum trace elements concentrations and serum biochemical parameters with the risk of polycystic ovary syndrome: a case-control study. Biol Trace Elem Res 2024; 202 (01) 73-86
• 64 Yin D, Mao R, Wang D. et al. Association of plasma metal levels with outcomes of assisted reproduction in polycystic ovary syndrome. Biol Trace Elem Res 2024; 202 (11) 4961-4977
• 65 Sun Y, Wang W, Guo Y. et al. High copper levels in follicular fluid affect follicle development in polycystic ovary syndrome patients: population-based and in vitro studies. Toxicol Appl Pharmacol 2019; 365: 101-111
• 66 Schmalbrock LJ, Weiss G, Rijntjes E. et al. Pronounced trace element variation in follicular fluids of subfertile women undergoing assisted reproduction. Nutrients 2021; 13 (11) 4134
• 67 Wang X, Zhang Y, Peng J. et al. Association between exposure to multiple toxic metals in follicular fluid and the risk of PCOS among infertile women: the mediating effect of metabolic markers. Biol Trace Elem Res 2024;
• 68 Sun K, Xie Y, Zhao N, Li Z. A case-control study of the relationship between visceral fat and development of uterine fibroids. Exp Ther Med 2019; 18 (01) 404-410
• 69 Liang C, Zhang Z, Cao Y. et al. Exposure to multiple toxic metals and polycystic ovary syndrome risk: endocrine disrupting effect from As, Pb and Ba. Sci Total Environ 2022; 849: 157780
• 70 Šimková M, Vítků J, Kolátorová L. et al. Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS?. Physiol Res 2020; 69 (Suppl. 02) S279-S293
• 71 Grgas D, Petrina A, Štefanac T, Bešlo D, Landeka Dragičević T. A review: per- and polyfluoroalkyl substances-biological degradation. Toxics 2023; 11 (05) 446
• 72 Buck RC, Franklin J, Berger U. et al. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr Environ Assess Manag 2011; 7 (04) 513-541
• 73 Zhan W, Qiu W, Ao Y. et al. Environmental exposure to emerging alternatives of per- and polyfluoroalkyl substances and polycystic ovarian syndrome in women diagnosed with infertility: a mixture analysis. Environ Health Perspect 2023; 131 (05) 57001
• 74 Li S, Li G, Lin Y. et al. Association between perfluoroalkyl substances in follicular fluid and polycystic ovary syndrome in infertile women. Toxics 2024; 12 (02) 104
• 75 Wang W, Zhou W, Wu S. et al. Perfluoroalkyl substances exposure and risk of polycystic ovarian syndrome related infertility in Chinese women. Environ Pollut 2019; 247: 824-831
• 76 Kim YR, White N, Bräunig J. et al. Per- and poly-fluoroalkyl substances (PFASs) in follicular fluid from women experiencing infertility in Australia. Environ Res 2020; 190: 109963
• 77 Hammarstrand S, Jakobsson K, Andersson E. et al. Perfluoroalkyl substances (PFAS) in drinking water and risk for polycystic ovarian syndrome, uterine leiomyoma, and endometriosis: a Swedish cohort study. Environ Int 2021; 157: 106819
• 78 Rutkowska A, Rachoń D, Bisphenol A. Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS). Gynecol Endocrinol 2014; 30 (04) 260-265
• 79 Prabhu NB, Adiga D, Kabekkodu SP, Bhat SK, Satyamoorthy K, Rai PS. Bisphenol A exposure modulates reproductive and endocrine system, mitochondrial function and cellular senescence in female adult rats: a hallmarks of polycystic ovarian syndrome phenotype. Environ Toxicol Pharmacol 2022; 96: 104010
• 80 Prabhu NB, Vasishta S, Bhat SK. et al. Distinct metabolic signatures in blood plasma of bisphenol A-exposed women with polycystic ovarian syndrome. Environ Sci Pollut Res Int 2023; 30 (23) 64025-64035
• 81 Yang Z, Shi J, Guo Z. et al. A pilot study on polycystic ovarian syndrome caused by neonatal exposure to tributyltin and bisphenol A in rats. Chemosphere 2019; 231: 151-160
• 82 Graceli JB, Dettogni RS, Merlo E. et al. The impact of endocrine-disrupting chemical exposure in the mammalian hypothalamic-pituitary axis. Mol Cell Endocrinol 2020; 518: 110997
• 83 Akgül S, Sur Ü, Düzçeker Y. et al. Bisphenol A and phthalate levels in adolescents with polycystic ovary syndrome. Gynecol Endocrinol 2019; 35 (12) 1084-1087
• 84 Jędrzejuk D, Kuliczkowska-Płaksej J, Milewicz A, Wilczewska K, Namieśnik J, Rutkowska A. Bisphenol A levels are negatively correlated with serum vitamin D-binding protein and sex hormone-binding globulin levels in women with polycystic ovary syndrome: a pilot study. Pol Arch Intern Med 2019; 129 (02) 133-136
• 85 Mina A, Boutzios G, Papoutsis I. et al. Bisphenol A correlates with fewer retrieved oocytes in women with tubal factor infertility. Hormones (Athens) 2022; 21 (02) 305-315
• 86 Majewska J, Berg A, Jurewicz J. et al. Bisphenol A analogues and metabolic syndrome in women with polycystic ovary syndrome. Reprod Toxicol 2024; 123: 108511
• 87 Gu J, Yuan T, Ni N. et al. Urinary concentration of personal care products and polycystic ovary syndrome: a case-control study. Environ Res 2019; 168: 48-53
• 88 Lazúrová Z, Figurová J, Hubková B, Mašlanková J, Lazúrová I. Urinary bisphenol A in women with polycystic ovary syndrome - a possible suppressive effect on steroidogenesis?. Horm Mol Biol Clin Investig 2021; 42 (03) 303-309
• 89 Thayer KA, Doerge DR, Hunt D. et al. Pharmacokinetics of bisphenol A in humans following a single oral administration. Environ Int 2015; 83: 107-115
• 90 Franko N, Kodila A, Sollner Dolenc M. Adverse outcomes of the newly emerging bisphenol A substitutes. Chemosphere 2024; 364: 143147
• 91 Zhang M, Liu C, Yuan XQ. et al. Individual and joint associations of urinary phthalate metabolites with polycystic ovary and polycystic ovary syndrome: results from the TREE cohort. Environ Toxicol Pharmacol 2023; 102: 104233
• 92 Akın L, Kendirci M, Narin F, Kurtoğlu S, Hatipoğlu N, Elmalı F. Endocrine disruptors and polycystic ovary syndrome: phthalates. J Clin Res Pediatr Endocrinol 2020; 12 (04) 393-400
• 93 Jin Y, Zhang Q, Pan JX, Wang FF, Qu F. The effects of di(2-ethylhexyl) phthalate exposure in women with polycystic ovary syndrome undergoing in vitro fertilization. J Int Med Res 2019; 47 (12) 6278-6293
• 94 Al-Saleh I. The relationship between urinary phthalate metabolites and polycystic ovary syndrome in women undergoing in vitro fertilization: nested case-control study. Chemosphere 2022; 286 (Pt 1): 131495
• 95 Park CJ, Oh JE, Feng J, Cho YM, Qiao H, Ko C. Lifetime changes of the oocyte pool: contributing factors with a focus on ovulatory inflammation. Clin Exp Reprod Med 2022; 49 (01) 16-25
• 96 Richardson MC, Guo M, Fauser BCJM, Macklon NS. Environmental and developmental origins of ovarian reserve. Hum Reprod Update 2014; 20 (03) 353-369
• 97 Yang Y, Huang W, Yuan L. Effects of environment and lifestyle factors on premature ovarian failure. Adv Exp Med Biol 2021; 1300: 63-111
• 98 Sydora BC, Wilke MS, McPherson M, Chambers S, Ghosh M, Vine DF. Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care. BMC Womens Health 2023; 23 (01) 569
• 99 Silva EL, Lane KJ, Cheng JJ. et al. Polycystic ovary syndrome underdiagnosis patterns by individual-level and spatial social vulnerability measures. J Clin Endocrinol Metab 2024; dgae705
• 100 Teede H, Tay CT, Laven J. et al. International evidence-based guideline for the assessment and management of polycystic ovary syndrome. 2023 . Published online February 2023. Accessed December 15, 2024 at: https://doi.org/10.26180/24003834.v1
• 101 Azziz R, Carmina E, Dewailly D. et al; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009; 91 (02) 456-488
• 102 Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond, B 1963; 158: 417-433
• 103 Hamzai L, Lopez Galvez N, Hoh E, Dodder NG, Matt GE, Quintana PJ. A systematic review of the use of silicone wristbands for environmental exposure assessment, with a focus on polycyclic aromatic hydrocarbons (PAHs). J Expo Sci Environ Epidemiol 2022; 32 (02) 244-258
• 104 Perrier F, Giorgis-Allemand L, Slama R, Philippat C. Within-subject pooling of biological samples to reduce exposure misclassification in biomarker-based studies. Epidemiology 2016; 27 (03) 378-388
• 105 Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics (Sao Paulo) 2015; 70 (11) 765-769
• 106 UN Environment Programme. Stockholm Convention on Persistent Organic Pollutants (POPs) Text and Annexes. Published online 2023. Accessed June 26, 2024 at: https://www.pops.int/Portals/0/download.aspx?d=UNEP-POPS-COP-CONVTEXT-2023.English.pdf
• 107 Bergman Å, Heindel JJ, Jobling S. et al, eds. State of the Science of Endocrine Disrupting Chemicals -2012. Published online June 12, 2012. Accessed October 29, 2024 at: https://www.who.int/publications/i/item/9789241505031
• 108 Li Y, Zhang M-w, Wang Y-j. Association between the persistent organic pollutants and polycystic ovary syndrome. Medicine (Baltimore) 2019; 98 (34) e16948
• 109 Guo Z, Qiu H, Wang L. et al. Association of serum organochlorine pesticides concentrations with reproductive hormone levels and polycystic ovary syndrome in a Chinese population. Chemosphere 2017; 171: 595-600
• 110 Vagi SJ, Azziz-Baumgartner E, Sjödin A. et al. Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study. BMC Endocr Disord 2014; 14: 86